Palla R, Marchitiello M, Tuoni M, Cirami C, Giovannini L, Bertelli A A, Bertelli A
Int J Clin Pharmacol Res. 1985;5(5):351-5.
Forty-one patients with urinary tract infections were randomly assigned to receive for six days gentamicin, amikacin, sisomicin or netilmicin. The dose for each patient was calculated according to creatinine clearance and lean body mass in order to avoid overdosages. Urinary enzymes (alpha-glucosidase, gamma-glutamyltranspeptidase and muramidase), serum creatinine and creatinine clearance, proteinuria and urinary sediment were evaluated for nephrotoxicity. None of the patients developed nephrotoxicity, but urinary enzymes rose significantly in all. The statistical analysis of enzymuria during the treatment permitted the definition of a rank order of the nephrotoxic potential of the aminoglycosides studied.
41例尿路感染患者被随机分配接受庆大霉素、阿米卡星、西索米星或奈替米星治疗6天。根据肌酐清除率和瘦体重计算每位患者的剂量,以避免用药过量。评估尿酶(α-葡萄糖苷酶、γ-谷氨酰转肽酶和溶菌酶)、血清肌酐和肌酐清除率、蛋白尿和尿沉渣以检测肾毒性。所有患者均未发生肾毒性,但尿酶均显著升高。对治疗期间的酶尿进行统计分析,确定了所研究氨基糖苷类药物肾毒性潜力的等级顺序。